Emily Bratton

Emily Bratton is a seasoned epidemiologist and expert in Real World Evidence, currently serving as a Senior Director at IQVIA, where they lead safety evidence initiatives for regulators using applied AI science. With a PhD in Epidemiology from the University of North Carolina at Chapel Hill, Emily has held various roles, including Adjunct Assistant Professor at UNC and Director of Epidemiology within Global Epidemiology at IQVIA. Previously, they contributed to research at GSK and Amgen while also gaining invaluable experience as a research technician at Duke University Medical Center. Emily's work encompasses a wide range of epidemiological studies and innovative strategies in late-phase clinical development, emphasizing collaboration across specialties.